Stocks
Denali Therapeutics (DNLI) P/S US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 62.4 | 27.2 | 111.4 | 0.00 | 0.00 | |||
| Changes by years, y/y, % | +321% | -56% | +310% | -100% | -100.0% | ||||
Denali Therapeutics. P/S
Denali Therapeutics. P/S, changes, %
Denali Therapeutics (DNLI) P/S US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| P/S | ? | 11.8 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Changes by years, y/y, % | -63% | -100% | -100% | -100% | ||||
| Changes by quarters, q/q, % | -62% | -100% | ||||||
